Dr. Sandeep Gupta, M.D

NPI: 1194990945
Total Payments
$4,000
2024 Payments
$151.83
Companies
33
Transactions
217
Medicare Patients
10,731
Medicare Billing
$975,146

Payment Breakdown by Category

Food & Beverage$3,244 (81.1%)
Travel$733.41 (18.3%)
Education$22.68 (0.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,244 207 81.1%
Travel and Lodging $733.41 7 18.3%
Education $22.68 3 0.6%

Top Paying Companies

Company Total Records Latest Year
Olympus Corporation of the Americas $785.82 8 $0 (2019)
GlaxoSmithKline, LLC. $547.38 55 $0 (2020)
AstraZeneca Pharmaceuticals LP $523.97 32 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $355.25 19 $0 (2020)
Mylan Specialty L.P. $273.77 18 $0 (2021)
Inspire Medical Systems, Inc. $244.74 2 $0 (2024)
Sunovion Pharmaceuticals Inc. $123.73 12 $0 (2019)
Insmed, Inc. $122.06 7 $0 (2022)
Philips Electronics North America Corporation $110.43 7 $0 (2020)
Merck Sharp & Dohme Corporation $98.04 7 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $151.83 7 Inspire Medical Systems, Inc. ($111.92)
2023 $16.15 5 Electromed, Inc. ($16.15)
2022 $43.66 3 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($28.66)
2021 $274.28 9 Inspire Medical Systems, Inc. ($132.82)
2020 $477.75 30 Mylan Specialty L.P. ($82.83)
2019 $1,637 66 Olympus Corporation of the Americas ($785.82)
2018 $704.46 55 GlaxoSmithKline, LLC. ($148.75)
2017 $695.74 42 Boehringer Ingelheim Pharmaceuticals, Inc. ($216.10)

All Payment Transactions

217 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
09/16/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $111.92 General
Category: NEUROLOGY
05/07/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $4.74 General
Category: HFCWO
05/07/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $1.82 General
Category: HFCWO
04/10/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $3.41 General
Category: HFCWO
03/14/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $5.03 General
Category: HFCWO
02/08/2024 Itamar Medical Inc WatchPATONE (Device) Food and Beverage Cash or cash equivalent $19.62 General
Category: Sleep Apnea testing
01/10/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $5.29 General
Category: HFCWO
11/07/2023 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $2.00 General
Category: HFCWO
10/13/2023 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $3.21 General
Category: HFCWO
08/29/2023 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $3.75 General
Category: HFCWO
06/28/2023 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $3.39 General
Category: HFCWO
03/22/2023 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $3.80 General
Category: HFCWO
02/24/2022 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Respiratory
01/14/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.87 General
Category: Gastroenterology
01/07/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.79 General
Category: Gastroenterology
12/07/2021 Inspire Medical Systems, Inc. Inspire Upper Airway Stimulation System (Device) Food and Beverage Cash or cash equivalent $132.82 General
Category: Neurology
11/04/2021 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $20.15 General
Category: Respiratory
07/21/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.24 General
Category: Gastroenterology
07/16/2021 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $17.76 General
Category: Respiratory
06/28/2021 Mylan Specialty L.P. Yupelri (Drug) Food and Beverage In-kind items and services $16.87 General
Category: Anticholinergics, Inhaled
03/09/2021 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $13.84 General
Category: PAH
03/02/2021 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.45 General
Category: NEUROSCIENCE
02/02/2021 Mylan Specialty L.P. Yupelri (Drug) Food and Beverage In-kind items and services $20.26 General
Category: Anticholinergics, Inhaled
02/01/2021 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $11.89 General
Category: Respiratory
12/17/2020 Takeda Pharmaceuticals U.S.A., Inc. GLASSIA (Biological) Food and Beverage In-kind items and services $21.52 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 2,530 3,424 $747,193 $212,494
2022 15 2,550 3,600 $689,018 $212,580
2021 21 2,937 4,110 $1.0M $286,882
2020 23 2,714 3,868 $968,141 $263,191
Total Patients
10,731
Total Services
15,002
Medicare Billing
$975,146
Procedure Codes
89

All Medicare Procedures & Services

89 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 155 422 $279,287 $64,594 23.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 202 351 $90,957 $30,471 33.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 245 523 $99,400 $30,157 30.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 238 300 $30,809 $20,594 66.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 140 152 $73,375 $18,925 25.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 334 394 $29,452 $17,586 59.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 165 165 $22,474 $15,442 68.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 39 40 $12,144 $3,809 31.4%
94010 Test to measure expiratory airflow and volume Facility 2023 466 504 $20,821 $2,888 13.9%
31652 Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes Facility 2023 17 17 $53,149 $2,655 5.0%
71046 X-ray of chest, 2 views Facility 2023 167 184 $4,600 $1,332 28.9%
94729 Test to examine how well the lungs exchange gases Facility 2023 183 187 $4,140 $1,184 28.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 12 $2,058 $799.92 38.9%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 25 27 $19,573 $759.11 3.9%
94618 Test for exercise-induced lung stress Facility 2023 32 32 $1,764 $498.30 28.2%
94727 Test to determine lung volumes using gas dilution or washout Facility 2023 61 61 $1,766 $466.01 26.4%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 34 34 $1,026 $221.85 21.6%
71045 X-ray of chest, 1 view Facility 2023 15 19 $399.00 $112.20 28.1%
99291 Critical care, first 30-74 minutes Facility 2022 135 445 $296,465 $71,864 24.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 202 457 $117,299 $34,600 29.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 247 341 $35,462 $24,159 68.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 159 167 $82,934 $24,018 29.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 182 404 $72,999 $21,314 29.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 278 314 $25,271 $14,948 59.2%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 127 127 $16,192 $12,344 76.2%

About Dr. Sandeep Gupta, M.D

Dr. Sandeep Gupta, M.D is a Pulmonary Disease healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1194990945.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Gupta, M.D has received a total of $4,000 in payments from pharmaceutical and medical device companies, with $151.83 received in 2024. These payments were reported across 217 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,244).

As a Medicare-enrolled provider, Gupta has provided services to 10,731 Medicare beneficiaries, totaling 15,002 services with total Medicare billing of $975,146. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Other Specialties Pulmonary Disease
  • Location Sioux City, IA
  • Active Since 04/23/2008
  • Last Updated 08/28/2015
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1194990945

Products in Payments

  • Olympus EBUS Bronchoscopes (Device) $785.82
  • SYMBICORT (Drug) $254.04
  • Yupelri (Drug) $233.86
  • NUCALA (Biological) $222.23
  • FASENRA (Drug) $192.99
  • Inspire Upper Airway Stimulation System (Device) $132.82
  • INSPIRE (Device) $111.92
  • Arikayce (Drug) $105.82
  • STIOLTO RESPIMAT (Drug) $95.52
  • STIOLTO (Drug) $93.72
  • BREO (Drug) $93.16
  • ZERBAXA (Drug) $86.53
  • BROVANA (Drug) $80.58
  • TRELEGY ELLIPTA (Drug) $76.91
  • MATRIXRIB (Device) $73.64
  • Spin (Device) $67.54
  • ANORO (Drug) $64.92
  • DUPIXENT (Biological) $59.95
  • UPTRAVI (Drug) $57.25
  • XIFAXAN (Drug) $51.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.